Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis

Area of Science:

• Neuroscience
• Neurodegenerative Disorders
• Molecular and Cellular Neuroscience

Background:

• Early Huntington's disease (HD) exhibits cortical excitatory/inhibitory (E/I) imbalance before motor and cognitive symptoms.
• This pre-symptomatic window offers a therapeutic opportunity to restore E/I balance and potentially slow disease progression.

Purpose of the Study:

• To investigate the impact of pre-symptomatic, cell-type-specific modulation of M1 motor cortex activity on HD progression.
• Specifically, examining the effects of altering pyramidal neuron and parvalbumin interneuron activity in the R6/2 HD mouse model.

Main Methods:

• Presymptomatic R6/2 HD mice underwent daily, cell-type-specific manipulation of M1 motor cortex activity for three weeks.
• Methods included dampening Emx1 pyramidal neuron excitation and increasing parvalbumin interneuron activity.

Main Results:

• Cell-type-specific modulation significantly alleviated HD-related motor coordination deficits.
• Dampening pyramidal neuron excitation or increasing interneuron activity improved motor function in pre-symptomatic HD mice.

Conclusions:

• Cell-type-specific modulation of cortical output represents a promising therapeutic strategy for Huntington's disease.
• Normalizing E/I balance in the cortex may offer a viable approach for treating HD and other neurodegenerative conditions.